These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8137875)

  • 1. Antinociceptive effect of lipopolysaccharide from Pantoea agglomerans on streptozotocin-induced diabetic mice.
    Kamei J; Iwamoto Y; Suzuki T; Misawa M; Kasuya Y; Nagase H; Okutomi T; Soma G; Mizuno D
    Eur J Pharmacol; 1994 Jan; 251(1):95-8. PubMed ID: 8137875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociceptive effect of L-arginine in diabetic mice.
    Kamei J; Iwamoto Y; Misawa M; Nagase H; Kasuya Y
    Eur J Pharmacol; 1994 Mar; 254(1-2):113-7. PubMed ID: 8206107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antinociceptive effect of oxycodone in diabetic mice.
    Nozaki C; Saitoh A; Tamura N; Kamei J
    Eur J Pharmacol; 2005 Nov; 524(1-3):75-9. PubMed ID: 16256106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinociceptive effect of dihydroetorphine in diabetic mice.
    Kamei J; Suzuki T; Misawa M; Nagase H; Kasuya Y
    Eur J Pharmacol; 1995 Feb; 275(1):109-13. PubMed ID: 7774657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the antinociceptive effects of oxycodone in diabetic mice.
    Nozaki C; Saitoh A; Kamei J
    Eur J Pharmacol; 2006 Mar; 535(1-3):145-51. PubMed ID: 16533506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supraspinal delta 1-opioid receptor-mediated antinociceptive properties of (-)-TAN-67 in diabetic mice.
    Kamei J; Kawai K; Mizusuna A; Saitoh A; Morita K; Narita M; Tseng LF; Nagase H
    Eur J Pharmacol; 1997 Mar; 322(1):27-30. PubMed ID: 9088866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of diabetes on the antinociceptive effect of (+/-)pentazocine in mice.
    Kamei J; Iwamoto Y; Misawa M; Nagase H; Kasuya Y
    Res Commun Chem Pathol Pharmacol; 1994 Apr; 84(1):105-10. PubMed ID: 8042002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice.
    Kamei J; Zushida K; Ohsawa M; Nagase H
    Eur J Pharmacol; 2000 Mar; 391(1-2):91-6. PubMed ID: 10720639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of diabetes on the antinociceptive effect of beta-endorphin.
    Kamei J; Kawashima N; Hitosugi H; Misawa M; Nagase H; Kasuya Y
    Brain Res; 1993 Aug; 619(1-2):76-80. PubMed ID: 8374794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of chronic treatment with naltrindole, a selective delta-opioid antagonist, on mu-opioid receptor-mediated antinociception in diabetic mice.
    Kamei J; Kawashima N; Iwamoto Y; Suzuki T; Nagase H; Misawa M; Kasuya Y
    Psychopharmacology (Berl); 1993; 113(2):167-71. PubMed ID: 7855177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of diabetes on pinacidil-induced antinociception in mice.
    Zushida K; Onodera K; Kamei J
    Eur J Pharmacol; 2002 Oct; 453(2-3):209-15. PubMed ID: 12398906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of delta 1-opioid receptors in the antinociceptive effects of mexiletine in mice.
    Kamei J; Saitoh A; Kasuya Y
    Neurosci Lett; 1995 Aug; 196(3):169-72. PubMed ID: 7501275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Streptozotocin-induced diabetes selectively reduces antinociception mediated by mu 1-opioid receptors, but not that mediated by mu 2-opioid receptors.
    Kamei J; Iwamoto Y; Hitosugi H; Misawa M; Nagase H; Kasuya Y
    Neurosci Lett; 1994 Jan; 165(1-2):141-3. PubMed ID: 8015716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antinociceptive effects of the selective non-peptidic delta-opioid receptor agonist TAN-67 in diabetic mice.
    Kamei J; Saitoh A; Ohsawa M; Suzuki T; Misawa M; Nagase H; Kasuya Y
    Eur J Pharmacol; 1995 Mar; 276(1-2):131-5. PubMed ID: 7781682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociceptive effects of (+)-matrine in mice.
    Kamei J; Xiao P; Ohsawa M; Kubo H; Higashiyama K; Takahashi H; Li J; Nagase H; Ohmiya S
    Eur J Pharmacol; 1997 Oct; 337(2-3):223-6. PubMed ID: 9430418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of the antinociceptive effect of spinally administered kyotorphin by naltrindole in mice.
    Ochi T; Ohkubo Y; Mutoh S
    Neurosci Lett; 2002 Apr; 322(2):95-8. PubMed ID: 11958852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive effects of the ORL1 receptor agonist nociceptin/orphanin FQ in diabetic mice.
    Kamei J; Ohsawa M; Kashiwazaki T; Nagase H
    Eur J Pharmacol; 1999 Apr; 370(2):109-16. PubMed ID: 10323258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociceptive effect of shakuyakukanzoto, a Kampo medicine, in diabetic mice.
    Omiya Y; Suzuki Y; Yuzurihara M; Murata M; Aburada M; Kase Y; Takeda S
    J Pharmacol Sci; 2005 Dec; 99(4):373-80. PubMed ID: 16314688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse.
    Sakurada S; Hayashi T; Yuhki M; Orito T; Zadina JE; Kastin AJ; Fujimura T; Murayama K; Sakurada C; Sakurada T; Narita M; Suzuki T; Tan-no K; Tseng LF
    Eur J Pharmacol; 2001 Sep; 427(3):203-10. PubMed ID: 11567650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of spinal delta1-opioid receptors in inhibiting the formalin-induced nociceptive response in diabetic mice.
    Kamei J; Kashiwazaki T; Hitosugi H; Nagase H
    Eur J Pharmacol; 1997 May; 326(1):31-6. PubMed ID: 9178652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.